Celldex Therapeutics CLDX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's total costs & expenses?
- Celldex Therapeutics (CLDX) reported total costs & expenses of $84.45M in Q1 2026.
- How has Celldex Therapeutics's total costs & expenses changed year-over-year?
- Celldex Therapeutics's total costs & expenses increased by 33.1% year-over-year, from $63.43M to $84.45M.
- What is the long-term trend for Celldex Therapeutics's total costs & expenses?
- Over 4 years (2021 to 2025), Celldex Therapeutics's total costs & expenses has grown at a 39.7% compound annual growth rate (CAGR), from $75.9M to $288.91M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company to support its business activities during a specific period. It includes research and development, general and administrative expenses, and other operational outlays necessary to maintain the business. Analyzing this figure provides a comprehensive view of the company's total burn rate and operational efficiency.